Company performance
Add to research
Current Price
as of Apr 21, 2025$2.64
P/E Ratio
7.04
Market Cap
$377.18M
Description
Add to research
PharmaEngine, Inc. engages in the research, development and manufacture of biopharmaceutical products. It develops drug treatments for pancreatic, gastric, brain, breast, head, neck, liver, rectal and prostate cancer; soft tissue sarcoma, and solid tumor. The company was founded by Chang Ching Yeh and Jung Chin Lin on August 12, 2002 and is headquartered in Taipei, Taiwan.
Metrics
Add to research
Overview
- HQTaipei, TP
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4162
- Price$2.643612-3.28%
Trading Information
- Market cap$377.18M
- Float82.02%
- Average Daily Volume (1m)1,071,036
- Average Daily Volume (3m)1,964,605
- EPS$12.19
Company
- Revenue$2.52B
- Rev growth (1yr)228.70%
- Net income$1.75B
- Gross margin98.11%
- EBITDA margin81.74%
- EBITDA$2.06B
- EV$9.14B
- EV/Revenue3.62
- P/E7.04
- P/S4.89
- P/B2.28
- Debt/Equity0.13
Documents
Add to research
Factset